All In Biotech

NDA 214988 · Be Pharms

Dehydrated Alcohol

Dehydrated Alcohol · Intravenous

Orphan

Last checked: Nov 20, 2026Latest source record: Oct 23, 2025 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

2025

Oct 23, 2025

Approved uses

1

Original approval plus efficacy supplements

Registered trials

1,532

244 Phase 3, 166 recruiting

FAERS reports

27,075

25,838 serious, 15,214 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

No structured label for this application in openFDA. Older and discontinued products often have none.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Oct 23, 2025 Original approval · Type 5 - New Formulation or New Manufacturer OrphanLabelLetter
1 products under this application
  • DEHYDRATED ALCOHOL · DEHYDRATED ALCOHOL 98% (5ML) · SOLUTION, INTRAVENOUS · Prescription

Clinical trials

Interventional ClinicalTrials.gov studies with "Dehydrated Alcohol" as an intervention, any sponsor and status, largest first.

All 1,532 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • toxicity to various agents6,095
  • completed suicide5,439
  • drug abuse5,341
  • overdose1,906
  • death1,608
  • intentional overdose1,554
  • suicide attempt1,374
  • cardio-respiratory arrest1,349
  • somnolence959
  • drug dependence932
  • drug interaction907
  • coma867

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
2004241
2005262
2006264
2007415
2008440
2009474
2010575
2011516
2012438
2013520
2014481
2015531
2016619
20172,140
20181,714
20192,118
20202,655
20211,650
20222,393
20232,567
20242,159
20252,074
20261,829

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 3 on PubMed

Sponsor: Be Pharms

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.